Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
Clinical trial NCT03166241 · UNKNOWN
Trial details
- NCT number
- NCT03166241
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2018-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.